The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase.
D000588:Amines / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D004357:Drug Synergism; D006220:Haloperidol / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007036:Hypothermia, Induced; D008297:Male; D010670:Phenylthiourea / Q000494:pharmacology; D010848:Picolinic Acids / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism
D000588:Amines; D002395:Catecholamines; D010848:Picolinic Acids; D012701:Serotonin; D010670:Phenylthiourea; D004299:Dopamine beta-Hydroxylase; D006220:Haloperidol; D002746:Chlorpromazine; D004298:Dopamine